New initiatives for transforming clinical research in Korea

Journal Title: Journal of Medicines Development Sciences - Year 2015, Vol 1, Issue 2

Abstract

Korea has continuously sought to improve its regulatory environment for clinical trials and has invested heavily in clinical trial infrastructure and technology since the early 2000’s. A strategic investment through the Korea National Enterprise for Clinical Trials (KoNECT) program began in 2007 and grew to encompass a network of regional clinical trial centers to promote clinical trial capabilities and human resource development. In early 2014, KoNECT became a permanent organization focused on the advancement of the country's clinical trial industry. This was followed by the establishment of the Korea Clinical Trials Global Initiative (KCGI) and the KoNECT Collaboration Center for global clinical trials (KCC). KCGI and KCC are now at the forefront of KoNECT’s efforts to promote higher operational efficiency in the country’s clinical trials. These new initiatives in clinical research are undertaking multichannel approaches to pursue a cohesive international collaboration model between government, industry and academia for the development of new treatments and improved patient care

Authors and Affiliations

Deborah Chee, Min Soo Park and Ji-Hoon Sohn

Keywords

Related Articles

TransCelerate: a global collaboration across biopharmaceutical R&D to accelerate and simplify new medicines development

As the economic pressures increase on healthcare systems around the world due to aging populations, chronic diseases, expanding patient populations in emerging markets and advances in medical technology, it is crucial th...

The Faculty of Pharmaceutical Medicine – Foundation, function and future

The Faculty of Pharmaceutical Medicine was established in the United Kingdom (UK) in 1989 to develop and maintain competence, ethics and the highest professional standards of practice in the discipline. This article char...

Investigative safety strategies to improve success in drug development

Understanding and reducing attrition rate remains a key challenge in drug development. Preclinical and clinical safety issues still represent about 40% of drug discontinuation, of which cardiac and liver toxicities are t...

European initiatives for better training in medicines development

In the last decade, the environment for medicines development has undergone unprecedented change, including: a shift from predominantly big Pharma to one of extensive industry–academia and SME partnerships and collaborat...

The Association for the Accreditation of Human Research Protection Programs: 15 years of emphasizing research safety, ethics, and quality

This year marks the 15th anniversary of the founding of the Association for the Accreditation of Human Research Protection Programs (AAHRPP), an organization that has been instrumental in strengthening protections for re...

Download PDF file
  • EP ID EP679250
  • DOI -
  • Views 205
  • Downloads 0

How To Cite

Deborah Chee, Min Soo Park and Ji-Hoon Sohn (2015). New initiatives for transforming clinical research in Korea. Journal of Medicines Development Sciences, 1(2), -. https://europub.co.uk./articles/-A-679250